Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease

Academic Article

Publication Date:

2018

Short description:

Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease / Fiorino, G., Ruiz-Arguello, M.b., Maguregui, A., Nagore, D., Correale, C., Radice, S., Gilardi, D., Allocca, M., Furfaro, F., Martinez, A., Danese, S.. - In: INFLAMMATORY BOWEL DISEASES. - ISSN 1078-0998. - 24:3(2018), pp. 601-606. [10.1093/ibd/izx086]

Iris type:

1.1 Articolo in rivista

List of contributors:

Fiorino, G; Ruiz-Arguello, Mb; Maguregui, A; Nagore, D; Correale, C; Radice, S; Gilardi, D; Allocca, M; Furfaro, F; Martinez, A; Danese, S

Authors of the University:

DANESE SILVIO

FURFARO FEDERICA

Handle:

https://iris.unisr.it/handle/20.500.11768/119555

Published in:

INFLAMMATORY BOWEL DISEASES

Journal